SCHEMBL2648115

SCHEMBL2648115

CCCOc1ccc(C(=O)Cc2ccncc2)c(OCCC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.46
NPC1 O15118 4/20 0.46
RAB9A P51151 2/20 0.46
LMNA P02545 5/20 0.44
HTT P42858 1/20 0.44
CYP3A4 P08684 3/20 0.43
CYP2D6 P10635 3/20 0.43
CYP2C9 P11712 2/20 0.43
ROCK2 O75116 1/20 0.43
ROCK1 Q13464 1/20 0.43
THRA P10827 1/20 0.43
THRB P10828 1/20 0.43
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
CYP19A1 P11511 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2648813 0.80 LMNA (0.48) SMN1; SMN2NPC1LMNACYP3A4CYP2D6
SCHEMBL9702617 0.77 PTPN11 (0.48) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1
SCHEMBL28529318 0.75 KMT2A (0.57) RAB9ALMNAHTTL3MBTL1KDM4E
SCHEMBL8218438 0.75 LMNA (0.55) SMN1; SMN2LMNACYP3A4CYP2C9CYP1A2
SCHEMBL17088991 0.75 LMNA (0.65) SMN1; SMN2NPC1LMNACYP3A4CYP2D6
SCHEMBL6835721 0.74 KMT2A (0.53) LMNAHTTCYP3A4CYP2D6CYP1A2
SCHEMBL28519834 0.73 TDP1 (0.51) LMNACYP2D6THRATHRBCYP1A2
SCHEMBL20496442 0.72 PLK1 (0.58) NPC1LMNACYP3A4CYP1A2CYP2C19
SCHEMBL20496466 0.71 LMNA (0.54) SMN1; SMN2LMNACYP3A4CYP2C9L3MBTL1
SCHEMBL19583373 0.70 THRA (0.52) THRATHRBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0959886-A4 TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS MERCK & CO INC (US) 2001-05-02 EP disclosed
EP-0959886-A1 TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS Merck & Co., Inc. (US) 1999-12-01 EP disclosed
US-5880139-A TREATING DIABETES, OBESITY, HYPERTENSION, CACHEXIA MERCK & CO., INC. (US) 1999-03-09 US disclosed
WO-1998022109-A1 TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS MERCK & CO., INC. (US) 1998-05-28 WO disclosed